Annual Congress Glasgow 2004

Saturday, 04.09.2004
Sunday, 05.09.2004
Monday, 06.09.2004
Tuesday, 07.09.2004
Wednesday, 08.09.2004

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 24: Suppl. 48, abstract number.


Material from 2004:
  • 3888 Abstracts
  • 555 Slide presentations
  • 20 Webcasts
  • 96 Handouts
Material from 2004:  Show

Comparing inhaled corticosteroids

Thematic Poster Session
Chairs: J. Mazzei (Buenos Aires, Argentina), C. M. Sanguinetti (Osimo, Italy)
Effectiveness of early intervention with budesonide in mild persistent asthma — 5-year data from the START study
W. Busse, R. Pauwels, S. Pedersen, W. Tan, Y. Z. Chen, C. J. Lamm, P. O‘Byrne (Madison, United States Of America; Ghent, Belgium; Kolding, Denmark; Singapore, Singapore; Beijing, China; Lund, Sweden; Hamilton, Canada)
Congress or journal article abstract
Congress or journal article abstract
The combination of budesonide and formoterol exerts more rapid and enhanced anti-inflammatory effects than either drug alone in rat lungs in vivo
A. Miller-Larsson, R. Brattsand (Lund, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Fluticasone propionate decreases β2- integrin-mediated eosinophil adhesion via increased annexin-1 surface expression
J. Liu, X. Zhu, S. Myo, A. Y. Meloton, N. M. Munoz, X. Chang, A. Lambertino, E. Boetticher, A. R. Leff (Chicago, United States Of America)
Congress or journal article abstract
Congress or journal article abstract
Synergistic action of formoterol on budesonide-generated decrease of proteoglycan production by activated lung fibroblasts is mediated via β-adrenergic receptor and is dependent on glucocorticoid receptor
L. Todorova, A. Miller-Larsson, G. Westergren-Thorsson (Lund, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Highly lipophilic fatty acid esters of the active metabolite of ciclesonide formed in vitro in rat lung tissue
R. Nave, B. Schmidt, R. Hummel, A. Wohlsen, R. Herzog, K. Zech (Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Tissue retention and esterification is greater for budesonide than for ciclesonide in trachea ex vivo
H. Gullstrand, K. Lexmüller, P. Sjölin, A. Smailagic, S. H. Korn, H. Jägfeldt, A. Miller-Larsson (Lund, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Greater esterification and retention of budesonide in the airways and lung as compared to ciclesonide after repeated intratracheal administration in vivo
H. Falk Nilsson, H. Gullstrand, P. Sjölin, S. H. Korn, H. Jägfeldt, A. Miller-Larsson (Lund, Sweden)
Congress or journal article abstract
Congress or journal article abstract
In vitro modulation of the cytokine-induced human bronchial epithelial cell (HBEC) functions by ciclesonide (CIC)
L. Serpero, L. Petecchia, M. Silvestri, F. Sabatini, G. A. Rossi (Genoa, Italy)
Congress or journal article abstract
Congress or journal article abstract
Glycosaminoglycan synthesis is modulated by ciclesonide in human lung cells
E. Papakonstantinou, G. Karakiulakis, M. Tamm, M. Roth (Thessaloniki, Greece; Basel, Switzerland)
Congress or journal article abstract
Congress or journal article abstract
Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma
S. Pedersen, K. Gyurkovits, K. H. E. von Delft, H. Boss, R. Engelstätter (Kolding, Denmark; Somogy, Hungary; Stellenbosch, South Africa; Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Ciclesonide and fluticasone propionate show comparable efficacy in children and adolescents with asthma
S. Pedersen, M. L. Garcia Garcia, A. I. Manjra, J. H. Vermeulen, L. Venter, R. Engelstätter (Kolding, Denmark; Ochoa, Spain; Durban, Capetown, Rivonia, South Africa; Konstanz, Germany)
Congress or journal article abstract
Congress or journal article abstract
Once daily ciclesonide and twice daily fluticasone propionate are equally effective in the treatment of patients with asthma
R. Buhl, I. Vinkler, P. Magyar, C. Rybacki, M. V. Middle, S. Wolf, R. Engelstätter (Mainz, Konstanz, Germany; Nyíregyháza, Budapest, Hungary; Bydgoszcz, Poland; George East, South Africa)
Congress or journal article abstract
Congress or journal article abstract
Mometasone furoate forms active metabolites and an active degradation product
A. Valotis, P. Hogger (Wurzburg, Germany)
Congress or journal article abstract
Congress or journal article abstract
Pharmacokinetic factors affecting airway selectivity of inhaled steroids – role of prodrug conversion and absorption
S. Edsbacker, C. J. Johansson (Lund, Sweden)
Congress or journal article abstract
Congress or journal article abstract
Mechanisms of systemic side effects of inhaled steroids
S. A. Mulrennan, J. S. Hogg, R. C. Teoh, A. H. Morice (Cottingham, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Decrease in fine T-cell subset ratio MT1/MT2 during steroid redution of asthmatic patients
H. J. H. Hoffmann, L. P. Nielsen, G. Blumberga, R. Dahl (Aarhus, Denmark)
Congress or journal article abstract
Congress or journal article abstract
Effects of inhaled corticosteroids on cough in asthma patients
N. Crispino, C. M. E. Tranfa (Naples, Italy)
Congress or journal article abstract
Congress or journal article abstract
The effect of applying inhaled corticosteroids in treating cough variant asthma
I. J. Stankovic, T. A. Pejcic, D. V. Djordjevic, M. H. Rancic, L. M. Ristic (Nis, Serbia & Montenegro)
Congress or journal article abstract
Congress or journal article abstract
Low dose theophylline restores steroid insensitivity in PBMCs of steroid insensitive asthma patients
M. Deguchi, Y. To, M. Ito, I. M. Adcock, P. J. Barnes, K. Ito (London, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract